Why the study?
Does carvedilol improve parasympathetic nervous system activity in patients with congestive heart failure?
Does carvedilol improve parasympathetic nervous system activity in patients with congestive heart failure?
Long-term carvedilol therapy substantially increases parasympathetic modulation of RR intervals in patients with chronic congestive heart failure.
May support carvedilol's autonomic effects in HF; leaves open confirmation of clinical benefit in randomized trials.
To determine the effect of beta blockade on parasympathetic nervous system activity, we assessed RR variability during 24-hour Holter monitoring in 10 patients with congestive heart failure before and after 3 to 4 months of treatment with the beta blocker carvedilol. High-frequency power increased from 26 to 64 ms2, root-mean-square of successive differences in RR interval increased from 14.3 to 23.7 ms2, and percentage of absolute differences >50 ms between successive normal RR intervals increased from 0.8% to 4.7%, all p <0.01, indicating a substantial increase in parasympathetic modulation of RR intervals.
No takes yet. Share an insight, caveat, or question.
Goldsmith et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: